Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Thursday, November 5, 2015

Pilot Study shows Promise for Improving brain function, neural plasticity and balance in MS patients

Multiple Sclerosis Pilot Study Evaluating PoNS Yields Promising

<span class="entry-title">Multiple Sclerosis Pilot Study Evaluating PoNS Yields Promising Results</span><span class="entry-subtitle">PoNS found to improve brain function, neural plasticity and balance in MS patients</span>

Helius Medical Technologies, Inc., a company dedicated to neurological wellness, recentlyannounced that the multiple sclerosis (MS) pilot study assessing the company’s investigational Portable Neuromodulation Stimulator (PoNS™) device has met all of the study’s goals.
PoNS is a non-invasive device that allows the delivery of neurostimulation through the tongue. The device is based on the concept that the tongue can be used as a natural, direct entry to stimulate the brain, especially since it is richly innervated by thousands of nerve fibers and interconnected by two major cranial nerves to the brainstem.
The PoNS system is currently being evaluated in Canada, at the Montreal Neurological Institute and Hospital and Concordia University’s PERFORM Center, as a therapy for gait and balance disorder in patients with MS. In total, 14 participants (7 with active MS and 7 control individuals) were submitted to this non-invasive brain stimulation technology along with physiotherapy. The potential clinical benefits of PoNS neurostimulation were evaluated and functional magnetic resonance imaging (fMRI) was employed to determine the device’s effect while participants performed working memory and mental imagery tasks, with or without stimulation.
fMRI results revealed that the PoNS device seems to facilitate neural plasticity. In fact, after treatment, patients with active MS exhibited a brain function similar to healthy individuals. MS patients also experienced a significant improvement in balance after 14 weeks of treatment. Furthermore, researchers reported a good safety profile for PoNS therapy.
MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide 
by signing up by clicking here

No comments: